Phase 1 Spinocerebellar ataxia Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2
Spinocerebellar Ataxia Type 2
Arrowhead Pharmaceuticals36 enrolled16 locationsNCT06672445
Recruiting
Phase 1Phase 2
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Spinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 1Huntington Disease
Vico Therapeutics B. V.68 enrolled14 locationsNCT05822908